Survival of Rat and Porcine Sertoli Cell Transplants in the Rat Striatum Without Cyclosporine-A Immunosuppression
Overview
Authors
Affiliations
The use of cyclosporine-A (CsA) immunosuppression for neural transplantation has become the treatment of choice for ameliorating host-graft rejection responses in human and animal transplant studies. However, the cytotoxic effects of CsA have warranted a search for alternative methods of protecting neural transplants. Sertoli cells produce an immunosuppressant factor, Fas ligand (Fas-L), that may provide the testis with its immunoprivileged status. Therefore, it has recently been suggested that these cells may be useful in producing localized immunosuppression for transplants. If Sertoli cells do produce localized immunosuppression, then it should be possible to successfully transplant Sertoli cells without additional immunosuppression following transplant surgery. The present study was undertaken to determine whether rat or porcine Sertoli cells transplanted into rat brain would survive for an extended period of time without CsA immunosuppression. Isolated rat or porcine Sertoli cells prelabeled with DiI were transplanted into normal rat brain. We report that both rat Sertoli cell allografts and porcine Sertoli cell xenografts survived for at least 2 months posttransplantation into the rat brain without CsA immunosuppression, indicating that these grafts were capable of producing sufficient localized immunosuppression to survive at the site of transplant without additional systemic immunosuppression.
Mesenchymal Stem Cell-Induced Anti-Neuroinflammation Against Traumatic Brain Injury.
Cozene B, Sadanandan N, Farooq J, Kingsbury C, Park Y, Wang Z Cell Transplant. 2021; 30:9636897211035715.
PMID: 34559583 PMC: 8485159. DOI: 10.1177/09636897211035715.
Mitochondrial activity of human umbilical cord mesenchymal stem cells.
Cozene B, Russo E, Anzalone R, La Rocca G, Borlongan C Brain Circ. 2021; 7(1):33-36.
PMID: 34084975 PMC: 8057105. DOI: 10.4103/bc.bc_15_21.
Bonsack B, Corey S, Shear A, Heyck M, Cozene B, Sadanandan N CNS Neurosci Ther. 2020; 26(6):603-615.
PMID: 32356605 PMC: 7248547. DOI: 10.1111/cns.13378.
Russo E, Lee J, Nguyen H, Corrao S, Anzalone R, La Rocca G Stem Cell Rev Rep. 2020; 16(3):585-595.
PMID: 32185666 PMC: 7253397. DOI: 10.1007/s12015-020-09967-8.
Hyperbaric oxygen therapy: A new look on treating stroke and traumatic brain injury.
Gonzales-Portillo B, Lippert T, Nguyen H, Lee J, Borlongan C Brain Circ. 2019; 5(3):101-105.
PMID: 31620655 PMC: 6785945. DOI: 10.4103/bc.bc_31_19.